A clinical-stage company in Bedford, MA, Rejoni Inc. revealed the completion of a $25 million funding round. This financing involved various investors like ClavystBio, Amed Ventures, Ascension Ventures, Catalyst Health Ventures, Delos Capital, FemHealth Ventures, Iyengar Capital, and Sparta Group. The funds will primarily support the development of the Juveena Hyd, a novel biomaterial therapy aimed at enhancing uterine health.